Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
First Commonwealth Financial EVP/CFO James R. Reske Sells $14.3K of Stock
James R. Reske, EVP/CFO, sold 699 shares of First Commonwealth Financial Corp at $20.51 a share, worth $14.3K in total on Oct 5, 2026. Shares held after the trade: 72,055 (-1.0%).
abrdn Emerging Markets ex-China Fund Insider Anthony S. Clark Buys $19.5K of Stock
Anthony S. Clark bought 2,000 shares of abrdn Emerging Markets ex-China Fund, Inc. at $9.73 a share, worth $19.5K in total on Oct 5, 2026. Shares held after the trade: 8,000 (+33.3%).
Federal Home Loan Bank of Pittsburgh $4.58B Debt Financing with Office of Finance
Federal Home Loan Bank of Pittsburgh reported the issuance of approximately $4.58 billion in consolidated obligation bonds and discount notes. These debt securities are joint and several obligations of the eleven Federal Home Loan Banks and are used to fund the bank's operations. The issuances include various fixed and variable rate instruments with maturities ranging from 2027 to 2046.
Rithm Perpetual Life Residential Trust declared monthly distributions of $0.1700 per share for its Class J and Class E common shares. The distributions are payable to shareholders of record as of September 30, 2026, and will be paid on or about October 20, 2026. The filing also noted the sale of approximately $1.5 million in common shares through its continuous private offering.
Federal Home Loan Bank of Indianapolis $620M Debt Financing with Federal Home Loan Banks
The Federal Home Loan Bank of Indianapolis has committed to becoming the primary obligor for $619.5 million in consolidated obligation bonds. The debt issuance consists of seven tranches with varying maturities ranging from January 2027 to October 2038, including both fixed-rate callable bonds and variable-rate non-callable floaters.
Warner Bros. Discovery M&A Deal with Skydance Corporation
Warner Bros. Discovery, Inc. (WBD) completed its merger with Skydance Corporation (SKYD) on October 6, 2026, with WBD becoming a wholly owned subsidiary of SKYD. In connection with the closing, WBD repaid its existing first lien credit facilities and certain subsidiaries entered into supplemental indentures to guarantee SKYD's debt obligations.
Apogee Enterprises reported Q2 fiscal 2027 net sales of $391.1 million, a 9.2% increase year-over-year, driven by the Kalwall acquisition and favorable pricing. The company raised its full-year adjusted diluted EPS guidance to a range of $3.00-$3.40, reflecting strong operational execution and productivity initiatives.
Term
Q2 2027
Earnings call
Oct 6, 2026, 9:00 AM ET
“We are pleased with the second-quarter results which exceeded our expectations, driven by strong execution across the business. The benefits of disciplined pricing, productivity initiatives, and ongoing operational improvements helped offset a mixed demand environment.”
Don Nolan, Executive Chair and Chief Executive Officer
“The momentum we established in the first half of the year, combined with our confidence in the business, supports our decision to raise full-year guidance. We also advanced our strategic priorities through the acquisitions of Kalwall and Groglass.”
Don Nolan, Executive Chair and Chief Executive Officer
Pyrophyte Acquisition Corp.'s sponsor, Pyrophyte Acquisition LLC, deposited $100,000 into the company's trust account to extend the deadline for completing an initial business combination. This represents the fourth monthly extension payment required to maintain the company's timeline through April 29, 2027.
ExchangeRight Income Fund's operating partnership amended its partnership agreement to create Class T Common Units. These units were specifically created to serve as consideration for the acquisition of a net-leased property to support the partnership's growth. The new units carry a fixed annual distribution rate of $1.650691 per unit and are subject to mandatory conversion into Class D Common Units upon certain events.
Nexentis Technologies amended several series of outstanding warrants to remove liability classification provisions and reclassify them as equity for accounting purposes. This action was taken specifically to help the company regain compliance with Nasdaq Listing Rule 5550(b)(1), which relates to minimum stockholders' equity requirements. The amendments do not change the exercise price, share count, or expiration dates of the warrants.
Contango Silver & Gold reported additional high-grade gold assay results from its 2026 surface drilling program at the Lucky Shot Project in Alaska, including 140.23 g/t gold over 0.63 meters. The company also provided an update on its underground exploration development, which has completed 54% of its planned 830-meter expansion and initiated drilling on the newly discovered KM vein system.
Repligen Corporation completed its acquisition of BioLife Solutions, Inc., a developer of cell processing tools for the cell and gene therapy market. Under the terms of the merger, BioLife stockholders received $11.25 in cash and 0.1442 shares of Repligen common stock for each share held. The deal expands Repligen's presence in the cell therapy workflow by adding BioLife's biopreservation media portfolio, including the CryoStor product line.
Counterparty
BioLife Solutions, Inc.
“BioLife’s highly-differentiated portfolio of products expands our presence in the rapidly growing cell therapy market, adding a deeply embedded, high-margin consumables business with attractive recurring revenue. Together, we are better positioned to support customers across critical stages of the cell therapy workflow and help advance the development and commercialization of next-generation therapies.”
Olivier Loeillot, President and Chief Executive Officer of Repligen
Biolife Solutions M&A Deal with Repligen Corporation
BioLife Solutions completed its merger with Repligen Corporation, becoming a wholly owned subsidiary of Repligen. BioLife stockholders received 0.1442 shares of Repligen common stock and $11.25 in cash for each share of BioLife common stock held. As a result of the completion, BioLife's common stock will be delisted from the Nasdaq Stock Market.
Paramount Skydance M&A Deal with Warner Bros. Discovery, Inc.
Paramount Skydance Corp (now Skydance Corporation) completed its acquisition of Warner Bros. Discovery, Inc., creating a combined global entertainment leader. In connection with the closing, the company issued $41.4 billion in senior secured notes and transferred its stock listing to the NYSE under the ticker 'SKYD'.
Tenable Holdings appointed Charles Bell, a former Microsoft and AWS executive, to its Board of Directors and Cybersecurity Risk Management Committee. Bell was granted 10,386 restricted stock units and will receive a prorated annual board retainer of $35,000 plus $5,000 for committee service. The appointment increases Tenable's board size from 10 to 11 members and adds significant cloud security and engineering expertise.
Bluejay Diagnostics announced baseline clinical characteristics from its SYMON-II clinical validation study, which is evaluating the Symphony IL-6 Test for mortality risk in sepsis patients. The study includes 777 evaluable patients with an 18% mortality rate, providing a diverse dataset to support the company's planned regulatory submission. The data showed that non-survivors had higher baseline illness severity, with septic shock present in 56.4% of that group.
Clean Energy Fuels Corp. appointed Jason J. Armstrong as Chief Financial Officer, succeeding Robert M. Vreeland effective October 6, 2026. Armstrong entered into an employment agreement with a $500,000 annual base salary, a target bonus of up to 100% of salary, and an incremental grant of 35,000 time-vesting restricted stock units.
Aflac Insider Japan Post Holdings Co. Ltd. Sells $1.47M of Stock
Japan Post Holdings Co. Ltd. sold 13,200 shares of Aflac Inc at $110.93 to $111.57 a share (average $111.30) in 2 transactions, worth $1.47M in total on Oct 2, 2026. Shares held after the trade: 50,420,190 (-0.0%).
Bion Environmental Technologies issued a correction to its fiscal year 2026 Annual Report regarding the status of its RNG project engineering. The company clarified that it has not yet executed agreements with engineering firms for pilot testing or FEL-2/3 studies, though discussions with several firms are ongoing alongside its partner Kimmeridge.
Gulf Resources, Inc. received a formal notification from Nasdaq stating that the company has regained compliance with periodic filing requirements under Listing Rule 5250(c)(1). The company had previously been in violation of continued listing standards, but the Staff has now determined the matter is closed.
Wheeler Real Estate Investment Trust Other 8-K Filing
Wheeler Real Estate Investment Trust issued 161,700 shares of common stock to Stilwell Investors in exchange for 30,800 shares of Series B and 7,700 shares of Series D Preferred Stock. The company also adjusted the conversion price of its 7.00% Subordinated Convertible Notes due 2031 to $2.73 per share following monthly Series D Preferred Stock redemptions. These transactions were conducted as exempt exchanges under Section 3(a)(9) with no cash proceeds received by the company.
Blue Bird $600M Debt Financing with Bank of Montreal
Blue Bird Corporation entered into a second amendment to its credit agreement, upsizing its senior secured credit facilities from $250 million to $600 million. The new arrangement includes a $300 million revolving credit facility and a $300 million delayed draw term loan, while extending the maturity date to September 30, 2031, and lowering interest rate margins.
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings, Inc. has filed a Notice of Variation to its existing tender offer to acquire all outstanding shares of Aurora Cannabis Inc. The amended offer increases the consideration to US$1.00 in cash plus 0.4013 Curaleaf subordinate voting shares per Aurora share and extends the expiry date to December 4, 2026.
TPG RE Finance Trust $874M Debt Financing with Wilmington Trust, National Association
TPG RE Finance Trust completed a $873.75 million collateralized loan obligation (CLO) transaction, TRTX 2026-FL8, through the issuance of several classes of senior secured floating rate notes. The notes are secured by a portfolio of commercial real estate mortgage loans and carry various interest rates based on a benchmark plus spreads ranging from 1.35% to 2.50%. The proceeds will be used to finance the company's lending operations and manage its capital structure.
Worksport reported preliminary August 2026 sales orders of $2.92 million, representing an annualized order run rate of $35.05 million. The company also disclosed preliminary net sales of $2.34 million for the month and an estimated backlog growth of 145% to approximately $898,000.
SHF Holdings (Safe Harbor) announced preliminary Q3 2026 deposit metrics, reporting that trailing 14-day average client deposits reached $119.3 million, a 7.4% year-over-year increase. The company also estimated that the Federal Reserve's recent 25-basis-point rate hike will add approximately $150,000 in incremental annualized investment income.
Powercompute Wins Contract from Columbus Light and Water
PowerCompute's subsidiary entered into a new Industrial Power Contract with Columbus Light and Water to increase contracted power at its Mississippi data center from 8.5 MW to 11 MW. The agreement transitions the facility to a specific Large Data Service Rate, successfully avoiding approximately $1.5 million per megawatt in new capacity commitment charges imposed by the Tennessee Valley Authority. Additionally, the utility returned a $300,000 cash deposit to the company, which will be replaced by a utility bond.
Microbot Medical Wins Contract from Medtechnica Ltd.
Microbot Medical Inc. entered into a three-year exclusive distribution agreement with Medtechnica Ltd. to market and sell the LIBERTY Endovascular Robotic System in Israel. The company expects initial orders under the agreement to begin in the fourth quarter of 2026 following prior regulatory approval from the Israeli Ministry of Health.
bioAffinity Technologies reported that sales of its CyPath Lung test increased more than 100% through the third quarter of 2026 compared to 2025. The company delivered 1,620 tests through Q3 2026, driven by an 89% increase in the number of ordering physician offices and expanded utilization by existing customers.